Evidence map›Paper›PMID 23436288›Full record

ArticleGlycobiology2013

Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures.

Danielle L Aldredge, Maria R Geronimo, Serenus Hua, Charles C Nwosu, Carlito B Lebrilla, Daniela Barile

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Glycobiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01814540 (Pilot Study), which is not on this map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01814540 nacompletednot on this map

Pilot Study: Tolerability of Feeding Different Doses of Bovine Milk Oligosaccharides for Modifying Gastrointestinal Function in Healthy Individuals

TypeinterventionalSponsorUniversity of California, DavisRan2012 to 2021Enrolled12ConditionsHealthyArmsBovine Milk Oligosaccharide, Placebo Glucose Polymer
3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Safety of 2'-fucosyllactose (2'-FL) produced by a derivative strain (EFSA journal. European Food Safety Authority · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Safety of 3-fucosyllactose (3-FL) produced by a derivative strain ofEFSA journal. European Food Safety Authority · 2023
    Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Danielle L AldredgeDepartment of Chemistry, University of California, Davis, CA 95616, USA.
Maria R Geronimo
Serenus Hua
Charles C Nwosu
Carlito B Lebrilla
Daniela Barile

Funding

UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
Necrotizing Enterocolitis: Prevention and PredictionR01HD059127 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEBRILLA, CARLITO B, MILLS, DAVID ANDREW · 2008 to 2012
$3.1M
Mechanism of Activation of Probiotic Bifidobacteria by Prebiotic Milk GlycansR01AT007079 · NCCIH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GERMAN, BRUCE, LEBRILLA, CARLITO B · 2012 to 2016
$2.2M
NCCIH NIH HHS 1R01AT007079-01NCCIH NIH HHS R01 AT007079NCRR NIH HHS UL1 RR024146NICHD NIH HHS HD059127NICHD NIH HHS R01 HD059127
6 · The paper itself

Abstract

Bovine milk oligosaccharides (BMOs) are recognized by the dairy and food industries, as well as by infant formula manufacturers, as novel, high-potential bioactive food ingredients. Recent studies revealed that bovine milk contains complex oligosaccharides structurally related to those previously thought to be present in only human milk. These BMOs are microbiotic modulators involved in important biological activities, including preventing pathogen binding to the intestinal epithelium and serving as nutrients for a selected class of beneficial bacteria. Only a small number of BMO structures are fully elucidated. To better understand the potential of BMOs as a class of biotherapeutics, their detailed structure analysis is needed. This study initiated the development of a structure library of BMOs and a comprehensive evaluation of structure-related specificity. The bovine milk glycome was profiled by high-performance mass spectrometry and advanced separation techniques to obtain a comprehensive catalog of BMOs, including several novel, lower abundant neutral and fucosylated oligosaccharides that are often overlooked during analysis. Structures were identified using isomer-specific tandem mass spectroscopy and targeted exoglycosidase digestions to produce a BMO library detailing retention time, accurate mass and structure to allow their rapid identification in future studies.

Indexed as

CattleAmino SugarsAnimalsCarbohydrate ConformationCarbohydrate SequenceChromatography, High Pressure LiquidFucoseGalactoseHumansIsomerismLactoseMilkMilk, HumanMolecular Sequence AnnotationOligosaccharidesTandem Mass SpectrometryAmino SugarsFucoseGalactoselactosamineLactoseOligosaccharidesbovine colostrumhigh-performance liquid chromatographyoligosaccharidestandem mass spectrometry

Identifiers

PMID23436288
PMCPMC3641798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.